Human medicines European public assessment report (EPAR): Onerji, levodopa,carbidopa, Date of authorisation: 27/04/2026, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Onerji, levodopa,carbidopa, Date of authorisation: 27/04/2026, Revision: 1, Status: Authorised

List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment

List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment

Managing product data quality in PMS: processes, known issues, current status and best practices, Online, from 21 July 2026, 14:00 (CEST) to 21 July 2026, 15:30 (CEST)

Managing product data quality in PMS: processes, known issues, current status and best practices, Online, from 21 July 2026, 14:00 (CEST) to 21 July 2026, 15:30 (CEST)

Substances considered as not falling within the scope of Regulation (EC) No. 470/2009, with regard to residues of veterinary medicinal products in foodstuffs of animal origin

Substances considered as not falling within the scope of Regulation (EC) No. 470/2009, with regard to residues of veterinary medicinal products in foodstuffs of animal origin

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - September 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2026, 10:00 (CEST) to 23 September 2026, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - September 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2026, 10:00 (CEST) to 23 September 2026, 12:00 (CEST)

Human medicines European public assessment report (EPAR): mCombriax, influenza mRNA vaccine,COVID-19 mRNA vaccine, Date of authorisation: 20/04/2026, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): mCombriax, influenza mRNA vaccine,COVID-19 mRNA vaccine, Date of authorisation: 20/04/2026, Revision: 1, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness